These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5126693)

  • 1. Evidence for a specific monoamine oxidase associated with sympathetic nerves.
    Goridis C; Neff NH
    Neuropharmacology; 1971 Sep; 10(5):557-64. PubMed ID: 5126693
    [No Abstract]   [Full Text] [Related]  

  • 2. Properties of monoamine oxidases in sympathetic nerve and pineal gland.
    Yang HY; Goridis C; Neff NH
    J Neurochem; 1972 May; 19(5):1241-50. PubMed ID: 5025123
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine oxidase in sympathetic nerves: a transmitter specific enzyme type.
    Goridis C; Neff NH
    Br J Pharmacol; 1971 Dec; 43(4):814-8. PubMed ID: 4339887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human brain monoamine oxidase: multiple forms and selective inhibitors.
    Youdim MB; Collins GG; Sandler M; Bevan Jones AB; Pare CM; Nicholson WJ
    Nature; 1972 Mar; 236(5344):225-8. PubMed ID: 4553640
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine oxidase activity of rat spinal cord after transection.
    Goridis C; Meek JL; Neff NH
    Life Sci I; 1972 Sep; 11(18):861-6. PubMed ID: 4511739
    [No Abstract]   [Full Text] [Related]  

  • 6. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence for specific monoamine oxidases in human sympathetic nerve and pineal gland.
    Goridis C; Neff NH
    Proc Soc Exp Biol Med; 1972 Jun; 140(2):573-4. PubMed ID: 5037594
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH; Tashjian AH
    Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
    [No Abstract]   [Full Text] [Related]  

  • 9. Monoamine oxidase: an approximation of turnover rates.
    Goridis C; Neff NH
    J Neurochem; 1971 Sep; 18(9):1673-82. PubMed ID: 5571107
    [No Abstract]   [Full Text] [Related]  

  • 10. Kinetic studies and effects in vivo of a new monoamine oxidase inhibitor, N-[2-(o-chlorophenoxy)-ethyl]-cyclopropylamine.
    Fuller RW
    Biochem Pharmacol; 1968 Oct; 17(10):2097-106. PubMed ID: 5696879
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition patterns of monoamine oxidase in sub-fractions of rat brain mitochondria in presence of some selective inhibitors.
    Mitra C; Guha SR
    Biochem Pharmacol; 1979 Apr; 28(7):1135-7. PubMed ID: 444271
    [No Abstract]   [Full Text] [Related]  

  • 12. A kinetic evaluation of monoamine oxidase activity in rat liver mitochondrial outer membranes.
    Houslay MD; Tipton KF
    Biochem J; 1974 Jun; 139(3):645-52. PubMed ID: 4850215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal monoamine oxidase: specific enzyme types and their rates of formation.
    Neff NH; Goridis C
    Adv Biochem Psychopharmacol; 1972; 5():307-23. PubMed ID: 4561511
    [No Abstract]   [Full Text] [Related]  

  • 14. Some observations upon a new inhibitor of monoamine oxidase in brain tissue.
    Johnston JP
    Biochem Pharmacol; 1968 Jul; 17(7):1285-97. PubMed ID: 5659776
    [No Abstract]   [Full Text] [Related]  

  • 15. Species differences in the deamination of dopamine and other substrates for monoamine oxidase in brain.
    Garrick NA; Murphy DL
    Psychopharmacology (Berl); 1980; 72(1):27-33. PubMed ID: 6781004
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacology of reversible and selective inhibitors of monoamine oxidase type A.
    Finberg JP
    Acta Psychiatr Scand Suppl; 1995; 386():8-13. PubMed ID: 7717096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular turnover numbers of different forms of mitochondrial monoamine oxidase in rat.
    Egashira T; Ekstedt B; Kinemuchi H; Wiberg A; Oreland L
    Med Biol; 1976 Aug; 54(4):272-7. PubMed ID: 957813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoamine oxidase. II. Time-dependent inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1974 Feb; 23(3):629-36. PubMed ID: 4822747
    [No Abstract]   [Full Text] [Related]  

  • 19. Occurrence and properties of monoamine oxidase in adrenergic neurons.
    Jarrott B
    J Neurochem; 1971 Jan; 18(1):7-16. PubMed ID: 5550080
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.
    Yang HY; Neff NH
    J Pharmacol Exp Ther; 1973 Nov; 187(2):365-71. PubMed ID: 4748552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.